AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments

B. Stamatopoulos , N. Meuleman , C. de Bruyn , K. Pieters , P. Mineur , C. Le Roy (1) , S. Saint-Georges , N. Varin-Blank (2, 3) , F. Cymbalista (4, 3) , D. Bron , L. Lagneaux

1 USC EA 3671 Mycoplasmal and chlamydial infections in humans
2 ASIH - Adaptateurs de signalisation en hématologie
3 UP13 - Université Paris 13
4 Service d'hématologie clinique [Avicenne]

Domaines: Sciences du Vivant [q-bio]

B. Stamatopoulos, N. Meuleman, C. de Bruyn, K. Pieters, P. Mineur, et al.. AMD3100 disrupts the cross-talk between chronic lymphocytic leukemia cells and a mesenchymal stromal or nurse-like cell-based microenvironment: pre-clinical evidence for its association with chronic lymphocytic leukemia treatments. Haematologica, 2012, 97 (4), pp.608-615. ⟨10.3324/haematol.2011.052779⟩. ⟨hal-02061460⟩